Literature DB >> 8684003

Hepatitis C virus infection and monoclonal gammopathies not associated with cryoglobulinemia.

A Mangia1, R Clemente, P Musto, I Cascavilla, P La Floresta, G Sanpaolo, R Gentile, M L Viglotti, D Facciousso, M Carotenuto, M Rizzetto, A Andriulli.   

Abstract

A pathogenetic role of HCV has been recently postulated in some lymphoproliferative disorders and in particular in essential mixed cryoglobulinemia. To assess the relevance of HCV infection in multiple myeloma, Waldenström's macroglobulinemia and monoclonal gammopathy of undetermined significance in the absence of cryoglobulinemia (cryo-ve MG), 102 patients were evaluated for antiHCV, HCVRNA and HCV genotypes. A control group of 466 patients referring for acute trauma to the Orthopedic Division of our hospital was also studied. The overall prevalence of HCV was 15.6% in MG patients and 5.4% in the control group (P= < 0.001). Since only patients with MG older than 50 years had HCV infection, we compared the prevalence rate of infection in patients aged 50 and older: in cryo-ve MG HCV prevalence was 17.9%, while in patients with an acute trauma it was 10%; the difference was not statistically significant. In addition, occurrence of cryo-ve MG was investigated in 614 antiHCV+ patients with chronic liver disease and was found in 1.9%. Comparing all the 28 cryo-ve MG patients HCV+ with an appropriately matched control group of HCV+ patients without MG, no difference in severity of liver disease and genotype distribution was detected. These findings show that: (1) among cryo-ve MG, HCV infection is frequent as shown in the appropriately matched control population; (2) prevalence of cryo-ve MG in antiHCV patients with chronic liver disease is similar to the rate found in the general population; and (3) HCV infection and disease do not differ in patients with and without cryo-ve MG.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8684003

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  6 in total

1.  Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients.

Authors:  John P Bida; Robert A Kyle; Terry M Therneau; L Joseph Melton; Matthew F Plevak; Dirk R Larson; Angela Dispenzieri; Jerry A Katzmann; S Vincent Rajkumar
Journal:  Mayo Clin Proc       Date:  2009-08       Impact factor: 7.616

Review 2.  Hepatitis C virus-related lymphoproliferative disorders: an overview.

Authors:  Anna-Linda Zignego; Carlo Giannini; Clodoveo Ferri
Journal:  World J Gastroenterol       Date:  2007-05-07       Impact factor: 5.742

3.  Antiviral treatment prioritization in HCV-infected patients with extrahepatic manifestations - An Egyptian perspective.

Authors:  Hussein El-Fishawy; Gamal Saadi; May Hassaballa; Mohamed Hussein; Wahid Doss; Gaafar Ragab; Rashad Barsoum
Journal:  J Adv Res       Date:  2016-03-02       Impact factor: 10.479

Review 4.  Hepatitis c and lymphoma.

Authors:  F Silvestri; A Sperotto; R Fanin
Journal:  Curr Oncol Rep       Date:  2000-03       Impact factor: 5.945

5.  Lack of evidence of hepatitis in patients with oral lichen planus in China: A case control study.

Authors:  Jiangyuan Song; Zhihui Zhang; Xiaoli Ji; Sha Su; Xiaodan Liu; Si Xu; Ying Han; Dongdong Mu; Hongwei Liu
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2016-03-01

6.  Eradication of Hepatitis C Virus Is Associated With Reduction in Hematologic Malignancies: Major Differences Between Interferon and Direct-Acting Antivirals.

Authors:  George N Ioannou; Pamela K Green; Kristin Berry; Solomon A Graf
Journal:  Hepatol Commun       Date:  2019-06-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.